What is the dosage of Breyanzi?

Breyanzi is available in 1 dosages, including 70,000,000 cells/ml Injection 4.6 ml

What does Breyanzi treat?

Breyanzi treats B-Cell Lymphoma

What is Breyanzi made of?

Breyanzi contains lisocabtagene maraleucel which is a undefined

How is Breyanzi administered?

Breyanzi is administered as a Injectable

What is Breyanzi mechanism of action?

Breyanzi mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Breyanzi

(lisocabtagene maraleucel)

4.6 ML lisocabtagene maraleucel 70000000 CELLS/ML Injection [Breyanzi]

BLACK BOX WARNING

Dosage & administration

For autologous use only. For intravenous use only.

* Do NOT use a leukodepleting filter .
* Administer a lymphodepleting regimen of fludarabine and cyclophosphamide before infusion of BREYANZI .
* Verify the patient’s identity prior to infusion .
* Premedicate with acetaminophen and an H1 antihistamine .
* Confirm availability of tocilizumab prior to infusion .
* Dosing of BREYANZI is based on the number of chimeric antigen receptor (CAR)-positive viable T cells .
* For LBCL after one line of therapy, the dose is 90 to 110 × 106 CAR-positive viable T cells .
* For LBCL after two or more lines of therapy, the dose is 50 to 110 × 106 CAR-positive viable T cells .
* Administer BREYANZI in a REMS-certified healthcare facility .

Breyanzi prescribing information

Have more Breyanzi questions?

Submit MSL Request

Learn More

Need to report a Breyanzi issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Breyanzi samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Breyanzi Prior authorization resources

Complete Letter of Medical Necessity

Coverage Authorization Request

Coverage Authorization Appeals

Breyanzi PA Tip Sheet

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Breyanzi Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Cell Therapy 360 Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Breyanzi Patient education